Myeloma

• Health & Medicine

European blood cancer survival improving

Survival rates for people with blood cancer have improved across Europe, but variations still exist from country to country. Survival rates for people with blood cancer have improved across Europe, but variations still exist from country to country.

15 July 2014

• Health & Medicine

Could measles cure cancer? Uh, not exactly...

Media outlets are awash with the news that researchers in the US have apparently cured cancer with the measles virus. What are the facts behind the headlines? Media outlets are awash with the news that researchers in the US have apparently cured cancer with the measles virus. What are the facts behind the headlines?

16 May 2014

• Health & Medicine
• Science & Technology

Notes from NCRI conference (day 4)

7 November 2012

Introducing our new Clinician Scientist Fellows

1 August 2012

• Health & Medicine

Misleading reporting of the “wonder jab that will kill 90% of cancers”

10 April 2012

• Health & Medicine
• Science & Technology

Scientists identify first genetic link to myeloma

For the first time researchers have identified genetic variations that influence a person's chances of developing a type of blood cancer called multiple myeloma, according to a British study part-funded by Cancer Research UK. For the first time researchers have identified genetic variations that influence a person's chances of developing a type of blood cancer called multiple myeloma, according to a British study part-funded by Cancer Research UK.

27 November 2011

• Health & Medicine

Is ecstasy ‘being developed to treat blood cancers’? Not quite…

19 August 2011

• Health & Medicine
• Science & Technology

Making research count for patients - the multiple myeloma story

27 June 2011

NICE recommends bortezomib and thalidomide for multiple myeloma

NICE has released guidance which recommends the drugs bortezomib and thalidomide as therapies for some patients with multiple myeloma. NICE has released guidance which recommends the drugs bortezomib and thalidomide as therapies for some patients with multiple myeloma.

26 August 2010

Protein regulates tumour cell growth in multiple myeloma

A protein known to be linked to inflammation may play an important role in the progression of some human cancers, scientists have revealed. A protein known to be linked to inflammation may play an important role in the progression of some human cancers, scientists have revealed.

11 September 2007

• Health & Medicine

Proof that controversial therapy is effective

Cancer Research UK scientists have for the first time shown that a controversial treatment is more effective than traditional chemotherapy for treating multiple myeloma, a cancer of the bone marrow. Cancer Research UK scientists have for the first time shown that a controversial treatment is more effective than traditional chemotherapy for treating multiple myeloma, a cancer of the bone marrow.

7 May 2003